FCS LABORATORIES INC
8-K/A, 1997-10-17
IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
Previous: SEILER POLLUTION CONTROL SYSTEMS INC, DEF 14A, 1997-10-17
Next: TRANSFINANCIAL HOLDINGS INC, SC 13D/A, 1997-10-17



<PAGE>
<PAGE>
_________________________________________________________________
_________________________________________________________________


                                                                

               SECURITIES AND EXCHANGE COMMISSION
                     Washington, D.C. 20549



                       FORM 8-K  AMENDED
                           
                         CURRENT REPORT          


               Pursuant to Section 13 or 15 (d)
            of the Securities Exchange Act of 1934



                        October 1, 1997
                    Date of Report (Date of
                    earliest event reported)



                     FCS LABORATORIES, INC.
     (Exact name of Registrant as specified in its charter)



                      Commission File Number
                            0-13154



        Arizona                               95-2568559
(State of Incorporation)              (I.R.S. Employer ID Number)



2330 S. Industrial Park Ave., Tempe, Arizona          85282
(Address of principal executive offices)           (Zip Code)



                         (602) 966-7248
      (Registrant's telephone number, including area code)


_________________________________________________________________
_________________________________________________________________<PAGE>
<PAGE>





Item 4 - Changes in the Registrant's Certifying Accountant


FCS Laboratories, Inc. (the "Company") announced the appointment
of Rosenberg Rich Baker Berman & Company to audit the Company's
books and records for the fiscal year ended September 30, 1997. 

The firm McGladrey & Pullen, LLP had served as the Company's
auditors during fiscal 1992, and since then they have continued
as the Company's accountant of record but did not provide any
substantive services, due to cost considerations only.  On
October 1, 1997, the Company made the decision, effective on that
date, to not reappoint McGladrey & Pullen, LLP, and to appoint
Rosenberg Rich Baker Berman & Company as the Company's
accountant.

The appointment will be submitted for ratification to the
Company's Shareholders at their next annual meeting.  The
decision of the Board of Directors of the Company was based on
the recommendation of its Audit Committee and was prompted by
cost considerations only.

In its announcement, the Company emphasized that there have been
no disagreements between the Company and McGladrey and Pullen,
LLP.  Their accountant's report on the 1992 financial statements,
the last statements actually audited, contained no adverse
opinion or disclaimer of opinion, although the report contained
an emphasis paragraph related to the Company's ability to
continue as a going concern, with which the Company was in
agreement.


Item 7 - Exhibits

     (c) Exhibit 16 - Letter on Change in Certifying Accountant












                              -2-<PAGE>
<PAGE>




                         Signature



Pursuant to the requirements of the Securities Exchange Act of
1934, the Registrant has duly caused this report to be signed on
its behalf by the undersigned, authorized officer.











Date:  October 17, 1997                FCS LABORATORIES, INC.



                                       /S/ Nicholas A. Gallo, III

                                       Nicholas A. Gallo, III
                                       Chairman, member of the
                                       Board of Directors and
                                       President

















 


                              - 3 -<PAGE>




<PAGE>
<PAGE>
EXHIBIT 16  -- LETTER ON CHANGE IN CERTIFYING ACCOUNTANT
_________________________________________________________________







October 15, 1997



Securities and Exchange Commission
Washington, DC 20549

Gentlemen:

We were previously principal accountants for FCS Laboratories,
Inc. and on April 9, 1993, except for the last paragraph of
Note 15 as to which the date was June 11, 1993, we reported on
the consolidated financial statement of FCS Laboratories, Inc.
and Subsidiaries as of and for the two years ended September 30,
1992 and 1991.  On October 6, 1997, we were notified of our
dismissal as principal accountants for FCS Laboratories, Inc. and
Subsidiaries.  We have read FCS Laboratories, Inc.'s statements
included under Item 4 of its amended Form 8-K dated October 17,
1997, and we agree with such statements insofar as they relate to
our Firm.

Very Truly yours,





McGLADREY & PULLEN, LLP















                              -4-<PAGE>
<PAGE>



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission